Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q1 2026 Earnings Call Transcript May 6, 2026
Taysha Gene Therapies, Inc. misses on earnings expectations. Reported EPS is $-0.12 EPS, expectations were $-0.1.
Operator: Good day, and thank you for standing by. Welcome to the Taysha Gene Therapies First Quarter 2026 Financial Results Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your first speaker...
